[Bruneomycin therapy of patients with Hodgkin's disease and neoplastic reticulosis].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D008206:Lymphatic Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010848:Picolinic Acids / Q000627:therapeutic use*; D011748:Pyrogallol / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D013308:Streptonigrin / Q000009:adverse effects / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D010848:Picolinic Acids; D011804:Quinolines; D011748:Pyrogallol; D013308:Streptonigrin
Lechenie bruneomitsinom bol'nykh limfogranulematozom i opukholevym retikulezom.